CHINAHEALTHWISE (00348) announced its interim results, with a loss attributable to shareholders of HKD 29.094 million, a shift from profit to loss compared to the same period last year.

CHINAHEALTHWISE (00348) announced its interim results for the six months ending June 30, 2026. The group reported revenue of HKD 36.462 million, a decrease of 28.59% year-on-year; the loss attributable to the company's owners for the period was HKD 29.094 million, compared to a profit of HKD 1.418 million in the same period last year; loss per share was HKD 0.0378. The announcement stated that the decline in revenue was due to (1) realized losses recognized when selling financial assets carried at fair value through profit or loss increasing from approximately HKD 200,000 in the corresponding period to approximately HKD 11.7 million in the current period; and (2) revenue from the Traditional Chinese medicine health products segment decreasing from approximately HKD 51 million in the corresponding period to approximately HKD 47.9 million in the current period.